Date Range
Date Range
Date Range
Novel Horizon 2020 research project FOLSMART starting off with the goal of an improved treatment method for Rheumatoid Arthritis. The FOLSMART consortium at the kick-off meeting at the European Commission in Brussels, January 19th 2016. A spin-off company with the mission of developing the FBN-products. Can be best understood as a virtual biotech start-up with an impressively validated core technology for chronic inflammatory diseases. The company will be responsible for the commercialization of all .
Deviant since Jul 11, 2007.
Institute of Psychiatry and Neurology. University Medical Center Hamburg-Eppendorf, UKE. Data and Safety Monitoring Board. PRECIOUS General Assembly Meeting in Barcelona.
National Institute of Health and Medical Research. A new Horizon 2020 project. A new Horizon 2020 project. A new Horizon 2020 project. A new Horizon 2020 project. A new Horizon 2020 project. A new Horizon 2020 project. METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration. For prevention of stroke and dementia.